{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:24:37Z","timestamp":1787725477507,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR22C1832"],"award-info":[{"award-number":["HR22C1832"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015499","name":"Jeonbuk National University","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100015499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110680"],"award-info":[{"award-number":["W81XWH2110680"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110711"],"award-info":[{"award-number":["W81XWH2110711"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["P50HD105328"],"award-info":[{"award-number":["P50HD105328"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001625","name":"Foundation to Eradicate Duchenne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2022R1C1C1006721"],"award-info":[{"award-number":["2022R1C1C1006721"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00236157"],"award-info":[{"award-number":["RS-2023-00236157"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020704","name":"Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MD970000"],"award-info":[{"award-number":["MD970000"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MD480160"],"award-info":[{"award-number":["MD480160"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtn.2025.102665","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:37:06Z","timestamp":1754433426000},"page":"102665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health"],"prefix":"10.1016","volume":"36","author":[{"given":"Young Jae","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Hindupur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iteoluwakishi H.","family":"Gamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki M.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-5185","authenticated-orcid":false,"given":"Jyoti K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102665_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","article-title":"Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis","volume":"15","author":"Crisafulli","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omtn.2025.102665_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102665_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2025.102665_bib5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102665_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s40265-023-01929-x","article-title":"Delandistrogene Moxeparvovec: First Approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.omtn.2025.102665_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nature.2016.20645","article-title":"US government approves controversial drug for muscular dystrophy","author":"Ledford","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102665_bib8","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of Novel Micro-dystrophins with Enhanced Functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jama.2024.5613","article-title":"The FDA and Gene Therapy for Duchenne Muscular Dystrophy","volume":"331","author":"Rind","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.omtn.2025.102665_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165869","article-title":"Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy","volume":"9","author":"Hart","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2025.102665_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1345","article-title":"Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology","volume":"12","author":"Alter","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102665_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102665_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2025.102665_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JND-200548","article-title":"Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls","volume":"8","author":"Mendell","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JND-210643","article-title":"Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial","volume":"8","author":"McDonald","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mus.28075","article-title":"Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls","volume":"70","author":"Iff","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtn.2025.102665_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/jamaneurol.2020.1264","article-title":"Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial","volume":"77","author":"Clemens","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtn.2025.102665_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/1389201043376706","article-title":"Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics","volume":"5","author":"Arora","year":"2004","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102665_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/nat.2016.0649","article-title":"Feasibility of SPECT-CT Imaging to Study the Pharmacokinetics of Antisense Oligonucleotides in a Mouse Model of Duchenne Muscular Dystrophy","volume":"27","author":"van de Steeg","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-017-00924-7","article-title":"Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle","volume":"8","author":"Novak","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102665_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/14728222.2018.1482279","article-title":"The macrophage as a Trojan horse for antisense oligonucleotide delivery","volume":"22","author":"Novak","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.omtn.2025.102665_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","article-title":"Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice","volume":"143","author":"Sacco","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102665_bib25","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1073\/pnas.80.15.4856","article-title":"Defective myoblasts identified in Duchenne muscular dystrophy","volume":"80","author":"Blau","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102665_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102446","article-title":"Role of Transforming Growth Factor-beta in Skeletal Muscle Fibrosis: A Review","volume":"20","author":"Ismaeel","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102665_bib27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3892\/etm.2017.4105","article-title":"Expression levels of TGF-beta1 and CTGF are associated with the severity of Duchenne muscular dystrophy","volume":"13","author":"Song","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omtn.2025.102665_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.omtn.2025.102665_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-020-20289-8","article-title":"TGFbeta signaling curbs cell fusion and muscle regeneration","volume":"12","author":"Girardi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102665_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.7","article-title":"Targeting TGF-beta Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-beta Type I Receptor","volume":"3","author":"Kemaladewi","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102665_bib31","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-022-34831-3","article-title":"Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-beta via Smad3 acetylation","volume":"13","author":"Osseni","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102665_bib32","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/s41467-022-34191-y","article-title":"Depletion of CD206(+) M2-like macrophages induces fibro-adipogenic progenitors activation and muscle regeneration","volume":"13","author":"Nawaz","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102665_bib33","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massague","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102665_bib34","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1172\/JCI39845","article-title":"Latent TGF-\u03b2\u2013binding protein 4 modifies muscular dystrophy in mice","volume":"119","author":"Heydemann","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102665_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135703","article-title":"TGF-beta-driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model","volume":"5","author":"Mazala","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2025.102665_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41420-023-01503-0","article-title":"Altered muscle niche contributes to myogenic deficit in the D2-mdx model of severe DMD","volume":"9","author":"Mazala","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.omtn.2025.102665_bib37","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.232157","article-title":"Cross-talk between TGF-beta and PDGFRalpha signaling pathways regulates the fate of stromal fibro-adipogenic progenitors","volume":"132","author":"Contreras","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omtn.2025.102665_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molmed.2021.10.003","article-title":"Pathogenic role and therapeutic potential of fibro-adipogenic progenitors in muscle disease","volume":"28","author":"Hogarth","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2025.102665_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtn.2025.102665_bib40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102665_bib41","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.celrep.2018.10.077","article-title":"AMPK Activation Regulates LTBP4-Dependent TGF-beta1 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy","volume":"25","author":"Juban","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2025.102665_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-210737","article-title":"Macrophages in Skeletal Muscle Dystrophies, An Entangled Partner","volume":"9","author":"Theret","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtn.2025.102665_bib44","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-beta Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2025.102665_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231182934","article-title":"Cardiac therapies for Duchenne muscular dystrophy","volume":"16","author":"Shah","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.omtn.2025.102665_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13395-015-0070-6","article-title":"Elusive sources of variability of dystrophin rescue by exon skipping","volume":"5","author":"Vila","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtn.2025.102665_bib47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JND-230107","article-title":"Increase in Full-Length Dystrophin by Exon Skipping in Duchenne Muscular Dystrophy Patients with Single Exon Duplications: An Open-label Study","volume":"11","author":"Nicolau","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib48","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.3233\/JND-210701","article-title":"Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy","volume":"8","author":"Benny Klimek","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2025.102665_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2006.03.005","article-title":"Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy","volume":"175","author":"Andreetta","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.omtn.2025.102665_bib51","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2025.102665_bib52","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1097\/00001756-200012180-00026","article-title":"Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy","volume":"11","author":"Ishitobi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.omtn.2025.102665_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtn.2025.102665_bib54","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/bc070060v","article-title":"Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate","volume":"18","author":"Amantana","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omtn.2025.102665_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/nat.2014.0528","article-title":"Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides","volume":"25","author":"Burki","year":"2015","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/mt.2010.288","article-title":"One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice","volume":"19","author":"Wu","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102665_bib57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2025.102665_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102665_bib59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.stem.2012.04.025","article-title":"Small molecule-mediated TGF-beta type II receptor degradation promotes cardiomyogenesis in embryonic stem cells","volume":"11","author":"Willems","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2025.102665_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvu229","article-title":"Pharmacological inhibition of TGFbeta receptor improves Nkx2.5 cardiomyoblast-mediated regeneration","volume":"105","author":"Chen","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtn.2025.102665_bib61","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.3233\/JND-210696","article-title":"Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping Therapy","volume":"8","author":"Novak","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2025.102665_bib62","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jcsm.13171","article-title":"The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47","volume":"14","author":"Heier","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omtn.2025.102665_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:17:33Z","timestamp":1782487053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2162253125002197"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102665","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102665"}}